CMC regulatory writing software that runs entirely in your browser Training guidesValidation packOpen the app

Module 3 sections · Training guide

Composition & General Info

Write nomenclature, structure, general properties, structure elucidation and the drug product composition, with molecular weight, CAS number, elemental analysis, salt factor and unit weight checked by calculation.

Writes
3.2.S.1.1 3.2.S.1.2 3.2.S.1.3 3.2.S.3.1 3.2.P.1
Product type
Small molecule
Guidance it follows
ICH M4Q(R1) 3.2.S.1, 3.2.S.3.1, 3.2.P.1; ICH Q6A; FDA Inactive Ingredient Database
Time to learn
About 20 minutes with the example

1. What this module does

This is usually the first module you open for a new product. It writes the identity sections of the drug substance (3.2.S.1.1 to 3.2.S.1.3 and 3.2.S.3.1) and the description and composition of the drug product (3.2.P.1).

Every number a reviewer can recalculate is recalculated: the molecular weight from the formula (IUPAC atomic weights), the CAS check digit, the elemental analysis against theory, the salt-to-free-base factor, the sum of the composition against the target unit weight, and the active quantity against the label strength.

What you get

  • Word or PDF files for 3.2.S.1.1 Nomenclature, 3.2.S.1.2 Structure, 3.2.S.1.3 General properties, 3.2.S.3.1 Elucidation of structure and 3.2.P.1 Description and composition.
  • A summary file for the QOS Composer & Dossier Assembler and the Process & Controls Writer (it reads the composition as the unit formula).

2. Before you start

Have these ready. You can still start with the example data and replace it piece by piece.

  • INN or USAN, company code, IUPAC name and CAS number.
  • Molecular formula of the salt and of the free base, and the molecular weight you state in the dossier.
  • Stereochemistry, and the techniques that confirm structure and configuration (NMR, MS, IR, X-ray, optical rotation).
  • Elemental analysis results (found %), if you have them.
  • The composition per unit with function and quality standard of each component, the strength, the target unit weight and the container closure.
Your data stays on your computer. The bar under the title counts every network request the page makes; it stays at 0 because your data never leaves your computer. Download offline copy saves a single file that opens from your own computer with all network access blocked, for air-gapped PCs.

3. Step by step with the example

Open the tool at app.cmcfy.com/app/composition-studio.html. The example is loaded when the page opens, so every panel already has realistic data. Follow the steps to see how it works, then replace the example with your own data.

  1. Choose what to write

    In panel 1 choose Sections to write: both drug substance and drug product, or only one of them. The panels you do not need are hidden. Set Submission region to US, EU or both.

    The tool opens with the example product CMX-101 Tablets, 50 mg already loaded.
    The tool opens with the example product CMX-101 Tablets, 50 mg already loaded.
  2. Enter nomenclature and structure

    Fill the INN, code, chemical name, CAS number and both molecular formulas. Write the formula as you would in the dossier, for example C22H22FN3O2·HCl. Type the molecular weight you state; the tool calculates its own and compares them.

  3. Read the result

    The result panel shows the formula as calculated (C22H23FN3O2Cl), the molecular weight from IUPAC atomic weights (415.89 g/mol), the salt factor (1.0961), the sum of the composition (340.27 mg) and the active quantity per unit (55.07 mg).

    Calculated molecular weight, salt factor, unit weight and active per unit.
    Calculated molecular weight, salt factor, unit weight and active per unit.
  4. Check elemental analysis and composition tables

    The tables under the result compare each element found with theory, and list the composition with the total. A difference of more than 0.4% absolute in elemental analysis, or a total that does not match the target unit weight, raises an alert.

    Elemental analysis against theory.
    Elemental analysis against theory.
  5. Resolve alerts

    The example has no blocking alerts in US mode. Switch the region to EU and alerts appear for each excipient whose quality standard cites USP/NF only: add the Ph. Eur. reference to fix them.

    Composition & General Info
  6. Preview and download

    Under Preview and download by CTD section, press Preview next to 3.2.S.1.1 to see the document with its review, then download Word or PDF. Press Download summary for QOS to save the summary file.

    Each section opens in a preview with the gap review on the left.
    Each section opens in a preview with the gap review on the left.

4. Field reference

Every input in the tool, panel by panel. Tables accept rows pasted straight from Excel, comma-separated text, or a loaded file; check the columns after loading a file. Fields marked “when it applies” appear only for the choices that need them.

1 · Scope

FieldWhat to enter
Sections to writeChoose one: Drug substance and drug product; Drug substance only (3.2.S.1, 3.2.S.3.1); Drug product only (3.2.P.1).
Submission regionChoose one: US: FDA (NDA, ANDA, BLA, IND); EU: EMA and national agencies (MAA); Both US and EU.
Drug product nameType it in.

2 · Drug substance: nomenclature and structure shown when it applies

FieldWhat to enter
INN or USANType it in.
Company codeType it in.
Chemical name (IUPAC)Type it in.
CAS registry numberType it in.
Molecular formula (salt)For a salt, write the salt formula with a middle dot, for example C22H22FN3O2·HCl. Type it in.
Molecular formula (free base, if a salt)Type it in.
Molecular weight stated (g/mol)The value you will state in the dossier; the tool compares it with its own calculation. Type a number.
StereochemistryType it in.
General propertiesA table. Columns: Property | Value. Paste rows from Excel, type comma-separated rows, or press Load file (Excel, CSV, Word, PDF or a scan).

3 · Drug substance: structure elucidation (3.2.S.3.1) shown when it applies

FieldWhat to enter
TechniquesA table. Columns: Technique | Result or conclusion | Batch. Paste rows from Excel, type comma-separated rows, or press Load file (Excel, CSV, Word, PDF or a scan).
Elemental analysisA table. Columns: Element | Found (%). Paste rows from Excel, type comma-separated rows, or press Load file (Excel, CSV, Word, PDF or a scan).

4 · Drug product: description and composition (3.2.P.1) shown when it applies

FieldWhat to enter
Dosage formType it in.
Strength (mg)Type a number.
Strength expressed asSays whether the label strength is expressed as free base or as the salt. Choose one: Free base; Salt as is.
Target unit weight (mg)Type a number.
Description of the dosage formType it in.
Composition per unitGive the active ingredient the function "Active ingredient" so the strength check can find it. A table. Columns: Component | Function | Quality standard | mg per unit | IID maximum for the route (mg, optional). Paste rows from Excel, type comma-separated rows, or press Load file (Excel, CSV, Word, PDF or a scan).
Container closure systemType it in.

5. Checks and alerts

Calculations and pass/fail outcomes always come from fixed rules, never from AI. The tool checks:

  • Molecular weight calculated from the formula and compared with the stated value; formulas that cannot be read are flagged.
  • CAS number check digit.
  • Stereochemistry described; for a chiral molecule, at least one technique that confirms the configuration (X-ray, chiral HPLC, optical rotation or VCD).
  • Elemental analysis: each element must be in the formula, and found must be within 0.4% of calculated.
  • Composition adds up to the target unit weight; an active ingredient is present; the active quantity matches the label strength after salt correction.
  • Every component has a function and a quality standard; quantities above the FDA Inactive Ingredient Database maximum you enter are flagged.
  • EU: excipients with a known effect (for example lactose) are listed for the labelling annex.

How to resolve alerts

  • Critical alerts block the download and must be fixed in the data. A failing result can instead be linked to an investigation: type the investigation reference and outcome and press Record.
  • Major alerts block the download until you fix them or type a justification and press Accept justification.
  • Minor alerts do not block anything. They are listed in the documents so the reviewer sees them.
  • Some alerts have an Apply fix button that makes the change for you. Reopen undoes a justification.

Narratives

This module writes: General properties (3.2.S.1.3); Elucidation of structure (3.2.S.3.1); Description and composition (3.2.P.1). Each narrative is written by fixed rules from your data. You can edit it in the box. Rewrite with AI (where your plan includes AI) rewrites it in regulatory style; every number in the text is checked against your data, and a number that does not match is flagged under the box and blocks the download until you correct it. Reset to rule-based text brings back the original.

6. Preview, gap review and download

  1. Press Preview next to a section, or Preview and download all. The document opens in a preview window, exactly as the Word file will read.
  2. The left side lists the review, run on your device: gaps in the data (missing values, open alerts), gaps in the report (missing content the guidance expects, placeholders such as [site] or TBD left in the text) and, if you load the approved protocol under Compare with the protocol, differences from the protocol (requirements, criteria, batches or time points it plans that the report does not show).
  3. Click a finding to jump to the place in the preview. Fix it in the tool, then preview again.
  4. Optional AI review: a second read for contradictions, claims without data and vague wording. The report text is sent to Claude only when you press it, and only where your plan includes AI. Check every AI finding; AI can be wrong.
  5. Press Download Word (.docx) or Download PDF. With several documents open, All as Word (.zip) and All as PDF (.zip) download the set. The download buttons stay disabled while a blocking alert is open; the preview still works.

Documents this module produces

SectionDocument
3.2.S.1.1Nomenclature
3.2.S.1.2Structure
3.2.S.1.3General properties
3.2.S.3.1Elucidation of structure and other characteristics
3.2.P.1Description and composition of the drug product

Use Save project to keep your work as a file on your computer, and Open project to continue later. Start blank clears every field; Load example brings the example back. Nothing is stored on CMCfy servers.

7. US and EU submissions

The sections are the same in both regions (ICH M4Q). In EU mode, compendial references are expected as Ph. Eur., so a quality standard that cites only USP/NF raises a minor alert, and excipients with a known effect are named as the EU excipients guideline requires. In US mode the FDA Inactive Ingredient Database limits are used when you enter them.

Choose Both US and EU to write one set of sections that cites both pharmacopoeias.

9. Common pitfalls

  • Writing the free-base formula in the salt field. The molecular weight then looks wrong by the weight of the counter-ion.
  • Stating the strength as free base but entering the salt quantity in the composition without choosing Free base under Strength expressed as.
  • Rounding the stated molecular weight differently from the certificate of analysis. Use the same value everywhere.
  • Leaving the container closure empty: 3.2.P.1 must name it, even though the detail goes in 3.2.P.7.

10. Practice exercises

Each exercise starts from the example (press Load example to reset). We run these on every update of this guide, so the result you see should match.

  1. Catch a molecular weight error

    Change Molecular weight stated (g/mol) from 415.90 to 420.

    Expected resultA major alert says the stated molecular weight 420 differs from the value calculated from the formula.

  2. Catch a mistyped CAS number

    Change the last digit of the CAS registry number from 4 to 5 (2412345-67-5).

    Expected resultA major alert says the CAS number fails the check-digit test.

  3. See the EU pharmacopoeia check

    Set Submission region to EU.

    Expected resultMinor alerts appear for excipients whose quality standard cites USP/NF only.